Unknown

Dataset Information

0

Aminoisoxazoles as Potent Inhibitors of Tryptophan 2,3-Dioxygenase 2 (TDO2).


ABSTRACT: Tryptophan 2,3-dioxygenase 2 (TDO2) catalyzes the conversion of tryptophan to the immunosuppressive metabolite kynurenine. TDO2 overexpression has been observed in a number of cancers; therefore, TDO inhibition may be a useful therapeutic intervention for cancers. We identified an aminoisoxazole series as potent TDO2 inhibitors from a high-throughput screen (HTS). An extensive medicinal chemistry effort revealed that both the amino group and the isoxazole moiety are important for TDO2 inhibitory activity. Computational modeling yielded a binding hypothesis and provided insight into the observed structure-activity relationships. The optimized compound 21 is a potent TDO2 inhibitor with modest selectivity over indolamine 2,3-dioxygenase 1 (IDO1) and with improved human whole blood stability.

SUBMITTER: Pei Z 

PROVIDER: S-EPMC5949840 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


Tryptophan 2,3-dioxygenase 2 (TDO2) catalyzes the conversion of tryptophan to the immunosuppressive metabolite kynurenine. TDO2 overexpression has been observed in a number of cancers; therefore, TDO inhibition may be a useful therapeutic intervention for cancers. We identified an aminoisoxazole series as potent TDO2 inhibitors from a high-throughput screen (HTS). An extensive medicinal chemistry effort revealed that both the amino group and the isoxazole moiety are important for TDO2 inhibitory  ...[more]

Similar Datasets

| S-EPMC6930675 | biostudies-literature
| S-EPMC7292271 | biostudies-literature
2019-12-29 | GSE138535 | GEO
| S-EPMC6318801 | biostudies-literature
| S-EPMC5150662 | biostudies-literature
| S-EPMC2939288 | biostudies-literature
| S-EPMC7153281 | biostudies-literature
| PRJNA576263 | ENA
| S-EPMC1221754 | biostudies-other
| S-EPMC2565576 | biostudies-literature